GlassScriptPhysician profile
Keegan Mcclary
NPI 1578983300
$7,639.22
in general payments reported to CMS, 2019-2025
29 companies · $936 in 2025
The $936 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $562 · 2020: $478 · 2021: $3,726 · 2022: $860 · 2023: $521 · 2024: $556 · 2025: $936.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,013.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,013.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $3,172.78 | 2021-2023 | Reactiv8 |
| Abbott Laboratories | $1,520.85 | 2019-2025 | Eterna, Proclaim, Octrode |
| Boston Scientific Corporation | $1,063.74 | 2019-2025 | General - Pain Management, General - Therapies |
| Nalu Medical, INC. | $406.47 | 2021-2025 | Nalu Neurostimulation System |
| Nevro Corp. | $278.95 | 2019-2024 | Senza |
| Globus Medical, INC. | $147.93 | 2025 | Senza |
| Vertos Medical, INC. | $110.93 | 2024 | Mild Device Kit |
| Biotronik Nro, INC. | $94.01 | 2025 | Prospera |
| Bioventus LLC | $83.54 | 2023-2024 | Durolane, Durolane |
| Medtronic USA, INC. | $80.72 | 2019-2020 | |
| Saluda Medical Americas, INC. | $78.39 | 2025 | Evoke |
| Radius Health, INC. | $74.70 | 2020-2021 | |
| Pacira Pharmaceuticals Incorporated | $64.02 | 2022-2024 | Iovera, Zilretta |
| Amgen INC. | $57.08 | 2019-2020 | |
| Medtronic, INC. | $46.82 | 2025 | Kyphon Express II Kyphopak Tray, Synchromedii |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $42.25 | 2025 | Optablate, Mild Device Kit |
| Collegium Pharmaceutical, INC. | $41.64 | 2019 | |
| Avanos Medical | $35.30 | 2021 | |
| Abbvie INC. | $32.25 | 2023 | |
| Merz North America, INC. | $32.11 | 2020 | |
| Depuy Synthes Sales INC. | $29.45 | 2022-2025 | Monovisc |
| Painteq LLC | $26.50 | 2021 | |
| Arbor Pharmaceuticals, INC. | $24.34 | 2019 | |
| Assertio Therapeutics, INC. | $19.44 | 2019 | |
| Lilly USA, LLC | $17.44 | 2019 | |
| Biodelivery Sciences International, INC. | $17.38 | 2019 | |
| Lemaitre Vascular, INC. | $14.27 | 2019 | |
| Si-Bone, INC. | $13.90 | 2024 | |
| Pfizer INC. | $12.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keegan Mcclary listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.